Life Sciences Tools and Services
Company Overview of Appistry Inc.
Appistry Inc. develops bioinformatics tools, cloud services, and software solutions that enable healthcare institutions to practice genomically enhanced medicine. Its tools streamline the analysis of data and make genomics data easier to clinical laboratories, research institutions, and hospital practices to act on. The company also provides Appistry CloudDx, a cloud-based system that help institutions conduct patient-centered translational research and hospitals to implement genome-scale tests based on next-generation sequencing (NGS) into routine patient care, as well as helps institutions deliver genomic tests. In addition, it offers CloudDx Translational, a cloud-based solution that cent...
1141 South 7th Street
St. Louis, MO 63104
Founded in 2001
Key Executives for Appistry Inc.
Chairman, Chief Executive Officer and President
Co-Founder, Chief Architect and Vice President of Engineering
Compensation as of Fiscal Year 2016.
Appistry Inc. Key Developments
Appistry Extends Solutions for Next-Generation Sequencing Data Analysis
Aug 11 16
Appistry announced extensions to their product line of genomics software solutions. Firstly the upcoming release of GenomePilot 4.0 will incorporate the capability to perform differential expression analysis of RNA-Seq data. GenomePilot 4.0 focuses on providing an easier way for customers to analyze RNA-Seq data by enabling differential expression analysis in three easy steps: Feature Counts – With a few clicks the user can define a feature count pipeline to identify gene counts for analysis. Experiment Builder – The innovative and intuitive Experiment Builder enables users to easily create an experiment with traits to be analyzed, while GenomePilot auto-populates gene counts into the workflow. Differential Expression – Users can quickly run differential expression analyses and visualize their results within one system without programming or working in multiple tools. Live demonstrations of GenomePilot 4.0 will be held in Appistry booth #40 at the upcoming Next Generation Dx Summit in Washington D.C.August 23-26 with customer availability on September 15, 2016. Secondly, Appistry will begin previewing a new product to the market, GenomeNavigator, which will focus on variant prioritization, clinical interpretation and reporting.
Appistry Enters Partnership with Washington University in St. Louis
May 24 16
Appistry announced that it has entered into a partnership with Washington University in St. Louis. Appistry will integrate the VarScan software, developed at the university’s McDonnell Genome Institute, for variant detection in massively parallel sequencing data with the company’s GenomePilot solution for next-generation sequencing data analysis in the clinical environment. VarScan is available in the current release of GenomePilot.
Appistry, Inc. Announces the Availability of GenomePilot on Microsoft's Azure Marketplace
Aug 19 15
Appistry Inc. announced the availability of GenomePilot on Microsoft’s Azure Marketplace. Through a new collaboration, Appistry will actively participate with Microsoft and other partners in the development of a complete set of cloud-based services for research and clinical genomics. Appistry will be working closely with Microsoft to develop, market, and sell genomics services on Azure, Microsoft’s cloud computing platform and integrated services that enable organizations to build and manage enterprise, production-grade infrastructures and applications easily, quickly, and cost-effectively. For an initial offering, Appistry is delivering its GenomePilot data analysis application on Azure to help research and clinical laboratories process and analyze the high volumes of genomics data produced by next-generation sequencing (NGS) technology. Initially released by Appistry in April 2015, GenomePilot provides a turnkey solution for NGS analysis by integrating tools, data, and processes into a single solution to help labs streamline their NGS analyses and increase productivity. For clinical labs operating under HIPAA or CLIA regulation, GenomePilot tracks all information associated with analysis runs for compliance auditing. Deployed on Azure, GenomePilot enables organizations to take advantage of these capabilities on a flexible, security-enhanced cloud infrastructure.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|